R
Revolution Medicines, Inc. (RVMD)
NMS – Real vaqt narxi. Valyuta: USD
145.72
+1.57 (1.09%)
Yopilishda: May 12, 2026, 4:00 PM EDT
147.01
+1.29 (0.89%)
Bozor oldidan: May 13, 2026, 4:31 AM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
145.72
+1.57 (1.09%)
Yopilishda: May 12, 2026, 4:00 PM EDT
147.01
+1.29 (0.89%)
Bozor oldidan: May 13, 2026, 4:31 AM EDT
This stock has a consensus price target of $111.26 based on the ratings of 31 analysts. The high is $215.00 and the low is $42.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 42 | $ 111.26 | $ 215 |
| O’zgarish | -70.86% | -22.82% | 49.15% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-04-22 | 16.33% | Leerink Partners | $147 → $171 | Maintains | Outperform |
| 2026-04-22 | 14.97% | HC Wainwright & Co. | $169 → $169 | Reiterates | Buy |
| 2026-04-20 | 46.27% | Stifel | $170 → $215 | Reiterates | Buy |
| 2026-04-20 | 26.54% | Needham | $145 → $186 | Maintains | Buy |
| 2026-04-14 | 13.61% | Wells Fargo | $144 → $167 | Maintains | Overweight |